The Delaware Journal of Public Health is delighted to partner with Delaware Business Times to raise awareness around public health matters, and to educate the community from legislators and policy makers to business leaders and the general population.
In 2015 the Delaware Journal of Public Health was launched. The Journal is published five times per year, and is the signature peer-reviewed journal of the Academy/DPHA. The DJPH is an electronic-only publication, produced to be platform-agnostic (visible on any device with any operating system as long as it has internet access), and dynamic with links out to other resources. Unlike a hardcopy publication, the DJPH can connect directly to other resources, studies, events, etc. as determined by the authors. We believe this model is in keeping with the times and patterns of access by our readership. It is also eco-friendly, and respects limited resources.
- There is NO COST to access the Journal for any interested reader. That means that all Delaware Business Times readers have access to the Journal.
- The Journal is PubMed indexed at https://pubmed.ncbi.nlm.nih.gov/?term=delaware+journal+of+public+health
- There is NO EMBARGO on reading the most recent issue.
- There are NO COSTS associated with submitting an article for review, or article processing costs.
- The ISSN for the Delaware Journal of Public Health is: 2639-6378 (click to validate).
- The DOI for the journal is 10.32481 and that number is always followed by “/” and an additional string of letters and numbers which identify the article on an individual basis.
Michael Fleming, Editor
We are starting this partner content partnership with the November 2023 issue on Biotechnology and Public Health. This issue of the DJPH focuses on Biotechnology, which plays a multifaceted role in public health improvement, ranging from early detection and prevention to the development of advanced treatments and interventions. The ongoing advancements in biotechnology continue to shape and enhance our ability to address public health challenges.
Guest edited by Delaware BioScience Association president Michael Fleming, these submissions from organization members demonstrate the breadth and impact of life science sector innovation on our state’s economy and public health. Examples include:
Vaccines
Biotechnology is instrumental in the development and production of vaccines. Recombinant DNA technology is often employed to create safer and more effective vaccines. Modern vaccine development, including mRNA vaccines like those for COVID-19, showcases the power of biotechnology in creating rapid and targeted responses to emerging public health threats.
Drug Development
Biotechnology contributes to the discovery and development of new drugs. Through genetic engineering and bioprocessing, researchers can produce therapeutic proteins, monoclonal antibodies, and other advanced pharmaceuticals. Targeted therapies, personalized medicine, and more effective treatments for various diseases are outcomes of biotechnological advancements.
Gene Therapy
Biotechnology allows for the development of gene therapies, offering potential cures for genetic disorders by replacing or repairing faulty genes. In the future, gene editing technologies like CRISPR may provide precise and targeted interventions for genetic diseases.
Surveillance and Monitoring
Biotechnology facilitates the monitoring of public health trends by providing tools for the surveillance of infectious diseases and other health-related parameters. Tracking and analyzing genetic information of pathogens help in understanding their evolution, transmission patterns, and potential outbreaks.
Environmental Health
Biotechnology contributes to environmental health by providing tools for monitoring and cleaning up pollutants. Bioremediation, for example, uses living organisms to remove or neutralize environmental contaminants. Genetically engineered organisms can be designed to break down pollutants, contributing to the improvement of environmental and public health.
Nutrition and Food Safety
Biotechnology is utilized in developing genetically modified crops with improved nutritional profiles, which can address malnutrition and related health issues. Biotechnological methods are also employed in ensuring food safety, such as the rapid detection of contaminants in the food supply chain.
Data Analysis and Bioinformatics
The field of bioinformatics, which combines biology and information technology, is crucial for analyzing large-scale biological data. This aids in understanding disease patterns, identifying risk factors, and developing targeted interventions.
In addition, in Delaware, the biotechnology industry is a growing component of the State’s economy, employing thousands at all levels. These advances in basic science can be seen as deeply impactful at the level of patient care and population health, especially as we increase our use of robotics, AI, and other key tech advancements to allow us to take better care of those we serve.
We hope you will enjoy and learn from this issue of the Journal, and as always, we look forward to your input and insights!
Please visit https://djph.org for this, and past issues, of the Journal!
